Ritonavir PSK

HIV/AIDS

Ritonavir PSK

Registration certificate:

INN:

Ritonavir

Release form:

Film-coated tablets

Therapeutic Area:

HIV/AIDS

Pharmacotherapeutic Group:

Antiviral agents for systemic use, Direct-acting antivirals, Protease inhibitors

Conditions for dispensing:

On prescription

Packaging:

Indications:

Ritonavir PSC is indicated for the treatment of HIV-1 infection (in adults and children over 3 years of age) as part of combination therapy.

Ritonavir PSK is in the Essential Medicines List.